AVA
Atlas Venture Advisors Portfolio holdings
AUM
$424M
This Quarter Return
+27.72%
1 Year Return
+0.16%
3 Year Return
+108.89%
5 Year Return
+64.67%
10 Year Return
–
AUM
$542M
AUM Growth
+$542M
(+21%)
Cap. Flow
-$12.9M
Cap. Flow
% of AUM
-2.39%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
8
New
–
Increased
–
Reduced
1
Closed
–
Top Buys
No buys this quarter
Top Sells
| 1 |
TBIO
Translate Bio, Inc. Common Stock
TBIO
|
$12.9M |
Sector Composition
| 1 | Consumer Discretionary | 82.49% |
| 2 | Healthcare | 11.66% |
| 3 | Communication Services | 5.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
DraftKings
DKNG
$23.8B
| $447M | 82.49% | 7,284,008 | – | – |
|
|
TBIO
2
DELISTED
Translate Bio, Inc. Common Stock
TBIO
| $30.9M | 5.7% | 1,872,115 -784,402 | -30% | -$12.9M |
|
3
Roku
ROKU
$14.2B
| $18.8M | 3.47% | 57,707 | – | – |
|
|
BCYC
4
Bicycle Therapeutics
BCYC
$511M
| $18.3M | 3.38% | 612,696 | – | – |
|
5
Snap
SNAP
$12.1B
| $12.8M | 2.37% | 245,559 | – | – |
|
|
FSTX
6
DELISTED
F-star Therapeutics, Inc. Common Stock
FSTX
| $6.23M | 1.15% | 574,996 | – | – |
|
7
Larimar Therapeutics
LRMR
$310M
| $4.27M | 0.79% | 292,184 | – | – |
|
8
Viridian Therapeutics
VRDN
$1.5B
| $3.5M | 0.65% | 209,505 | – | – |
|